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Both nitrogen monoxide (NO) and carbon monoxide (CO) are biologically relevant diatomic effector molecules that mediate a variety of
biological functions through their avid binding to iron (Fe). Previous studies showed that NO can inhibit Fe uptake from transferrin (Tf) and
increase Fe mobilisation from cells [J. Biol. Chem. 276 (2001) 4724]. We used CO gas, a CO-generating agent ([Ru(CO)3Cl2]2), and cells
stably transfected with the CO-producing enzyme, haem oxygenase 1 (HO1), to assess the effect of CO on Fe metabolism. These results were
compared to the effects of NO produced by a variety of NO-generating agents, including S-nitrosoglutathione (GSNO), spermine-NONOate
(SperNO) and S-nitroso-N-acetylpenicillamine (SNAP). Incubation of cells with CO inhibited 59Fe uptake from 59Fe–Tf by cells, and like
NO, reduced ATP levels. Hence, the ability of both agents to inhibit 59Fe uptake may be partially mediated by inhibition of energy-dependent
processes. These results showing a CO-mediated decrease in 59Fe uptake from 59Fe–Tf using exogenous CO were in agreement with studies
implementing cells transfected with HO1. Like NO, CO markedly prevented 59Fe uptake into ferritin. In comparison to the avid ability of
exogenous CO to inhibit 59Fe uptake, it had less effect on cellular 59Fe mobilisation. Experiments with HO1-transfected cells compared to
control cells showed that 59Fe mobilisation was slightly enhanced. In contrast to NO, CO did not affect the RNA-binding activity of the iron
regulatory protein 1 that plays an important role in Fe homeostasis. Our studies demonstrate that subtle differences in the chemistry of NO
and CO results in divergence of their ability to affect Fe metabolism.
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1. Introduction three products formed from the degradation of haem by theOften considered as a noxious gas, carbon monoxide
(CO) is paradoxically synthesized daily in the human body
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Refs. [1,2]). Acting in concert with cytochrome P450
reductase (CPR) and biliverdin reductase, HO degrades
haem to liberate CO, Fe(II) and biliverdin that is subse-
quently reduced to bilirubin [1,2].
Carbon monoxide is a small, membrane-permeable mole-
cule that has been compared with nitrogen monoxide (NO)
[1,2]. Both CO and NO have a high affinity for iron (Fe),
share some chemical properties in terms of their coordina-
tion chemistry, and exert similar biological effects [1,2].
Some of their most significant effector functions are via
their ability to bind Fe, for example, in the haem centre of
guanylate cyclase [1,2]. However, unlike NO, CO binds
Fe(II) but not Fe(III) in haemoproteins, and CO cannot S-
nitrosylate free sulfhydryl groups to act as a biological
effector [2]. These differences between NO and CO initiate
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another physiological outcome [1,2].
Iron is an essential for proliferation due to its role in
crucial metabolic processes including DNA synthesis (for
review, see Ref. [3]). In serum, Fe is transported by its
specific binding to the protein, transferrin (Tf). The Fe–Tf
complex enters cells by binding to the Tf receptor 1 (TfR1)
which is endocytosed [3]. Endosomal pH is then reduced to
approximately 5.5 by a proton pump resulting in the
dissociation of Fe from Tf. The membrane protein, Nramp2
(also known as DMT1, DCT1, and SLC11A2), transports Fe
from the endosome into the cytosol, where it then joins a
poorly characterized labile Fe pool [2,3]. From this pool, Fe
can be used in the synthesis of Fe-containing proteins or
stored in ferritin (for review, see Ref. [3]).
The intracellular Fe pool regulates two mRNA-binding
molecules known as the iron regulatory proteins 1 and 2
(IRPs) (for reviews, see Refs. [3,4]). Both IRP1 and IRP2
are trans-regulators that post-transcriptionally control the
expression of molecules which play essential functions in Fe
homeostasis [3,4]. The IRPs bind to hairpin-loop structures
called iron-responsive elements (IREs). These IREs are
found in the 3V- or 5V-untranslated regions (UTRs) of several
mRNAs including those encoding the ferritin H- and L-
subunits, Nramp2, ferroportin1 and the TfR1. The binding
of IRPs to the single IRE that is found in the 5V-UTR of
ferritin mRNA inhibits translation [3,4]. In contrast, binding
of the IRPs to the 3V-UTR of TfR1 mRNA increases its
stability that results in higher TfR1 levels and enhanced Fe
uptake from Tf [3,4].
Intracellular Fe levels regulate the binding of IRP1 and
IRP2 to the IREs via different mechanisms [3,4]. High Fe
levels promote the assembly of an [4Fe–4S] cluster in IRP1,
with loss of IRE-binding activity. In cells depleted of Fe, the
[4Fe–4S] cluster is not present, and under these conditions,
IRP1 can bind to the IRE [3,4]. In contrast to IRP1, IRP2
does not contain an [4Fe–4S] cluster, and is degraded in Fe-
replete cells via the proteasome [5].
Over the last 10 years, NO has been shown to have a major
role in Fe metabolism by its ability to increase IRP1-RNA-
binding activity [4]. This effect is thought to be due to the
ability of NO to directly interact with the [4Fe–4S] cluster
and also to remove Fe from cells [6,7]. Investigations in our
laboratory have shown that this NO-mediated depletion of Fe
is energy-dependent and requires reduced glutathione (GSH)
[8,9]. Interestingly, NO decreases Tf-mediated Fe uptake by
cells but does not mediate this process by directly removing
Fe from the Fe-binding site of this molecule [9,10]. In fact,
the ability of NO to reduce Fe uptake from Tf is at least
partially mediated via its ability to decrease ATP [9], that is
required for receptor-mediated endocytosis of Tf [3,11,12].
Interestingly, Ferris et al. [13] recently reported that cells
transfected with both haem oxygenase 1 (HO1) and CPR
cDNA have decreased Fe uptake from Tf and increased Fe
efflux compared to cells transfected with CPR only. Further,
in the same study, genetic deletion of HO1 increased Feuptake from Tf and decreased Fe mobilisation [13]. Hence, it
is possible that CO generated by HO1 may have similar
effects on Fe metabolism as those reported for NO [2–4,6,8–
10,14,15]. However, Ferris et al. [13] did not demonstrate that
these effects on Fe uptake or release were due to direct
interaction of CO with Fe, or mediated by the other products
of HO1, namely biliverdin, bilirubin or Fe(II). Further evi-
dence that HO1 affects Fe metabolism is suggested by
experiments using HO1 knockout mice [16]. These animals
suffer Fe-deficiency anaemia and Fe accumulation in the liver
or kidneys [16]. These latter results were similar to those in a
patient with genetic HO1 deficiency [17].
The differential effects of CO and NO have been
assessed in a variety of previous studies [1,2], although
their effects have not been compared on the metabolism of
Fe, which is a major intracellular target of these molecules.
The current investigation was performed to compare the
effects of CO and NO on Fe metabolism and IRP-RNA-
binding activity. To determine if the effects were due to CO
alone and not from another HO1 product, authentic CO gas
and the CO donor, tricarboxydichlororuthenium(II) dimer
([Ru(CO)3Cl2]2), were used [18]. Obviously, these agents
are metabolic probes that have been used to determine the
effects of CO on the cell and the results have been compared
to those obtained with cells stably transfected with HO1.
Our studies show that like NO, CO decreased Fe uptake
from Tf and its incorporation into ferritin. These results
were in agreement with experiments using cells stably
expressing HO1 and CPR, where decreased Tf–Fe uptake
was observed compared to those transfected with CPR
alone. However, unlike NO, exogenous CO did not increase
Fe efflux from seven cell types. Further, unlike NO, CO did
not appreciably increase IRP-RNA-binding activity. There-
fore, although NO and CO share similarities in their
coordination chemistry, there are differences that cause
divergence in their effects on Fe metabolism.2. Materials and methods
2.1. Reagents
Apotransferrin (apoTf), L-buthionine-(S,R)-sulfoximine
(BSO), Pronase (from Streptomyces griseus), reduced
GSH, ruthenium(III) chloride hydrate (RuCl3H2O; abbre-
viated to RuCl3), and [Ru(CO)3Cl2]2 were purchased from
Sigma-Aldrich Ltd. (St. Louis, MO, USA). S-nitrosogluta-
thione (GSNO) was purchased from Cayman Chemicals
(Ann Arbor, MI, USA).
The NO-generator, S-nitroso-N-acetylpenicillamine
(SNAP), was synthesized by established techniques de-
scribed previously [8,10] using the precursor compound
N-acetylpenicillamine (NAP; Sigma). Spermine-NONOate
(SperNO) was obtained from Molecular Probes (Oregon,
USA). Iron-59 (as ferric chloride in 0.1 M HCl) was
purchased from Dupont-NEN (Boston, MA, USA). Eagle’s
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chased from Invitrogen (Carlsbad, CA, USA). The Fe
chelator, desferrioxamine (DFO), was obtained from Novar-
tis Pharmaceutical Co. (Basel, Switzerland). The CO gas
mixture was purchased from Linde Gas (Sydney, Australia)
and was composed of 2% CO, 21% O2 and 77% N2. All
other chemicals were of analytical reagent quality. Reagents
were prepared and used on the day of the experiment.
2.2. Cell culture
Murine LMTK fibroblasts and human Kelly neuroblas-
toma cells were obtained from the European Collection of
Cell Cultures (Salisbury, Wiltshire, UK). The following
human cell lines were obtained from the American Type
Culture Collection (Rockville, MD, USA), including:
MCF7 breast cancer cells, HT1080 fibrosarcoma cells
(kindly provided by Prof. P.J. Hogg, University of New
South Wales, Sydney), SK-Mel-28 melanoma cells, SK-
Mel-2 melanoma cells, KLE adenocarcinoma cells, and SK-
N-MC neuroepithelioma cells. All cell lines were grown in
Eagle’s modified MEM containing 10% foetal calf serum
(FCS; Trace Scientific, Sydney, Australia), 100 Ag/ml strep-
tomycin (Invitrogen), 100 U/ml penicillin (Invitrogen) and
0.28 Ag/ml fungizone (Invitrogen). Where the effect of
D-glucose on NO-mediated 59Fe release was examined (such
as when implementing the GSH inhibitor, BSO), we used
Rosewall Park Memorial Institute (RPMI) medium with and
without D-glucose (Gibco).
The LMTK cell line was used in most of our studies as
the effect of NO on their Fe metabolism is well-character-
ized [6,8,9,19,20]. Human embryonic kidney (HEK-293)
cells stably transfected with human CPR or HO1 and CPR
(HO1/CPR) were obtained from Prof. S.H. Snyder and Dr.
David E. Baranano (Department of Neuroscience, The
Johns Hopkins University School of Medicine, MD, USA)
and cultured as described [13]. The transfection of both
HO1 and CPR were necessary in order to cause effective
degradation of haem [13]. As an appropriate negative
control, cells transfected with CPR alone were used [13].
All cells were grown in an incubator (Forma Scientific) at
37 jC with a humidified 5% CO2/95% air environment.
Cellular growth and viability were carefully assessed by
phase contrast microscopy and Trypan blue exclusion.
2.3. Nitrite determination
The accumulation of nitrite in cell culture supernatants is
commonly used as a relative measure of NO production [6].
Nitrite was assayed using the Griess reagent that gives a
characteristic spectral peak at 550 nm [21].
2.4. Carbon monoxide determination
The presence of CO in cell culture media was measured
spectrophotometrically by assessing the formation of car-boxyhaemoglobin (COHb) from oxyhaemoglobin (oxyHb)
[22,23].
2.5. ATP assay
Cellular ATP levels were determined by the Sigma ATP
assay kit (Cat. #366) with minor modifications as described
previously [8,9].
2.6. Glutathione assay
Measurement of GSH was performed using the GSH
Assay kit from Calbiochem (Cat. #354102; Calbiochem-
Novabiochem Corporation, San Diego, CA). The only
modifications to the protocol were that 10-fold more cells
(2.4 107 cells/assay) were used, and the cells were
disrupted using two rounds of freeze– thawing before
homogenisation as specified by the kit protocol. These
modifications markedly improved the sensitivity of the
technique.
2.7. Protein preparation and labelling
ApoTf was labelled with 59Fe (Dupont NEN) using
established techniques [24,25]. The protein concentration
and Fe-binding site saturation were determined by UV–Vis
spectroscopy using a Beckman DU-640 spectrophotometer at
280 nm (q 14,000 M 1 cm 1) and 465 nm (q 4260 M 1
cm 1), respectively. In some experiments, 59Fe–Tf was also
labelled with 125I (Dupont NEN) by standard methods
[24,25].
To determine the effect of CO on the Fe-binding sites
of diferric Tf, Tf (140 AM) labelled with non-radioactive
56Fe was incubated for 180 min at 37 jC under the same
conditions as that used for 59Fe uptake and 59Fe efflux
experiments (see below). The UV–Vis absorption spec-
trum of Tf was compared to the untreated control.
Particular attention was paid to the absorption peak at
465 nm, which is characteristic of the Tf–Fe-binding sites
[26].
OxyHb was prepared from erythrocytes taken from a
human volunteer by procedures described previously [10].
The concentration of oxyHb was determined using q541 13.8
mM 1 cm 1 [10].
2.8. Determination of 59Fe uptake by cells
The amount of 59Fe uptake from 59Fe–Tf by cells was
determined by standard techniques [24,25]. Briefly, cells
were grown to near confluence in 35 mm tissue culture
plates and then labelled with 59Fe–Tf ([Tf] = 0.75 AM;
[Fe] = 1.5 AM) in the presence or absence of test reagents.
In the case of CO gas, Petri dishes containing the cell
monolayer were incubated in the presence of 2% CO in a
modular incubator chamber (ICN, CA, USA) for up to 180
min at 37 jC. After this incubation, the cells were placed on
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Internalised 59Fe was determined using established proce-
dures by incubating cells on ice for 30 min in the presence
of an ice-cold solution of the general protease, Pronase
(1 mg/ml; [24,25]). Cells were removed from the plate using
a plastic spatula and centrifuged for 1 min at 12,740 g/4
jC. The supernatant and cell pellet were then separated and
counted individually on a g-counter (LKB Wallac, Wizard
3U, Turku, Finland).
2.9. Determination of 59Fe efflux from cells
To determine the amount of 59Fe mobilised from cells
after treatment with various agents, standard protocols were
used [8,20]. Briefly, cells were labelled for various times
with 59Fe–Tf ([Tf] = 0.75 AM; [Fe] = 1.5 AM) at 37 jC and
then washed four times with ice-cold PBS. The PBS was
removed and the cells incubated with medium in the
presence or absence of 2% CO gas and/or other test reagents
for up to 180 min at 37 jC. At the completion of the efflux
period, the overlying medium and cells were separated and
assessed for radiation on the g-scintillation counter de-
scribed above.
2.10. Native-PAGE 59Fe-autoradiography for the determi-
nation of intracellular 59Fe distribution
To determine the intracellular Fe pools that NO and CO
affect, 59Fe native-PAGE autoradiography was used and
performed using standard techniques described previously
[20,27–29].
2.11. IRP-RNA gel retardation assay
Cells were treated with either medium containing FCS
in the presence or absence of 100 AM DFO (a positive
control), or 50–150 AM of [Ru(CO)3Cl2]2 or its relevant
control, RuCl3, for 24 h at 37 jC. The Ru–CO complex
was used in these experiments in preference to CO gas
as incubations with the latter resulted in cytotoxicity
after 3 h at 37 jC. Incubations with [Ru(CO)3Cl2]2 at
concentrations to 150 AM enabled incubations of up to
24 h without significant toxicity. The cells were washed
four times with ice-cold PBS and lysed at 4 jC with
ice-cold Munro extraction buffer [30]. Established tech-
niques [6,19,30] were used to assess IRP-RNA-binding
activity.
2.12. Statistics
Experimental data were compared using Student’s t-test.
Results were considered statistically significant when
P < 0.05. Results are expressed as the mean of duplicate
determinations in a typical experiment of two to five
performed or as meanF S.D. of triplicate determinations
in a typical experiment of two to six performed.3. Results
3.1. Both NO and CO inhibit cellular iron uptake from
transferrin
Carbon monoxide and NO have similar chemical prop-
erties, in particular, they both bind Fe(II) to form coordina-
tion complexes in biological molecules, particularly those
containing haem [1,2]. We described previously [9] that at
least part of the activity of NO at inhibiting 59Fe uptake
from 59Fe–Tf was via its ability to deplete cellular ATP
levels. Ferris et al. [13] have shown that cells transfected
with HO1 and CPR have decreased Fe uptake. However,
these investigators did not distinguish whether this was due
to CO alone or to one of the other products of HO1 activity
[13]. To examine the effect of CO alone on cellular 59Fe
uptake from 59Fe–Tf, we incubated cells with authentic CO
gas (2%) and compared this with the well-described ability
of NO to inhibit 59Fe-uptake from 59Fe–Tf [9,10]. Cells
were labelled with 59Fe–Tf in the presence and absence of
the NO-generator GSNO (0.5 mM) or CO for 5–180 min at
37 jC. Incubation with 2% CO gas for longer than 180 min
resulted in cell death, whereas at this latter time point 90–
95% of LMTK  cells were still viable (data not shown).
Hence, in all experiments with 2% CO gas, only incubations
up to 180 min were used.
Control LMTK cells labelled with 59Fe–Tf showed
that 59Fe uptake increased linearly as a function of time
(Fig. 1A), as found using other cell types [24]. In accor-
dance with our previous studies [9], incubation of cells
with the NO generator, GSNO, decreased 59Fe uptake from
59Fe–Tf to 45% of the control after a 180 min incubation
at 37 jC (Fig. 1A). Experiments with GSH alone (the
negative control for GSNO) had no effect on 59Fe uptake
from 59Fe–Tf (data not shown) [9]. The ability of GSNO
to reduce 59Fe uptake from 59Fe–Tf was found with
various NO-generating agents (e.g., SNAP and SperNO
but not their control compounds, NAP and spermine,
respectively) that do not have the NO moiety [9,10]. These
observations indicate that the response observed was a
general effect of NO.
The NO-mediated inhibition of 59Fe uptake from 59Fe–
Tf can be seen after a 120 min incubation at 37 jC (Fig.
1A). In comparison, CO decreased 59Fe uptake from 59Fe–
Tf at 15 min (Fig. 1A, inset), where 59Fe uptake decreased
to 57% of the control. However, this CO-dependent de-
crease in 59Fe–Tf uptake was equal to 13% of the relevant
control after a 180 min incubation (Fig. 1A). The synthetic
CO generator [Ru(CO)3Cl2]2 (25–150 AM) was less effec-
tive than CO gas, and after a 180 min incubation, reduced
59Fe uptake from 59Fe–Tf to 62F 3% (meanF S.D., three
determinations) of the control at a concentration of 150 AM
(data not shown).
In the current study, the effect of CO and NO cannot be
directly compared, as we were assessing 2% CO gas
compared to NO produced in solution by the chemical
Fig. 1. Both CO gas and GSNO reduce: (A) 59Fe uptake from 59Fe-transferrin (59Fe–Tf) and (B) 59Fe incorporation into ferritin by LMTK fibroblasts. (C)
The uptake of 59Fe from 59Fe–Tf is reduced in HO1/CPR-transfected HEK-293 compared to their CPR-transfected counterparts. (A) Cells were labelled with
59Fe–Tf (0.75 AM) for 5–180 min at 37 jC in the presence or absence of 2% CO gas or GSNO (0.5 mM). The cells were then washed four times on ice and
incubated for 30 min with Pronase (1 mg/ml) at 4 jC to separate internalised from membrane-bound 59Fe. (B) The LMTK cells were labelled with 59Fe–Tf
(0.75 AM) for 60–180 min at 37 jC, washed, and native-PAGE 59Fe-autoradiography performed (see Materials and methods for details). Densitometric
analysis is presented below the autoradiograph. (C) Cells transfected with both CPR and HO1 or CPR alone were labelled with 59Fe–Tf (0.75 AM) for 180 min
at 37 jC, washed, and 59Fe uptake determined as described in panel (A). The results in panel (A) are expressed as means of duplicate determinations in a typical
experiment of five performed, while the results in panel (B) are representative of three separate experiments. The results in panel (C) are expressed as
meanF S.D. (three determinations) in a typical experiment of two performed.
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mine the concentration of CO in incubation media after a
180 min incubation with 2% CO gas. This was done by
taking an aliquot of medium after the incubation, adding
oxyHb (35 AM), and monitoring spectrophotometrically the
formation of COHb [22,23]. Using our experimental proto-
col, this assay was not sensitive enough to accurately
determine the low levels of CO in solution. In contrast to
these conditions, when oxyHb was added to the media and
then subsequently incubated for 3 h at 37 jC in the presence
of CO, it acted as a ‘‘sink’’ for this gas. Indeed, oxyHb was
shown by UV–Vis spectrophotometry to be converted to
COHb [22].
To estimate the level of CO in culture media in the
absence of oxyHb, we used Henry’s Law [31] and the
solubility and density of CO at 37 jC (1.83 ml/100 ml;
q = 1.1007 g/l) to calculate a concentration of 14.4 AM. This
approximation assumed equilibrium between the gas and
solvent phases had been reached during the 180 min incu-
bation. Since the production of CO in the body is about 500
Amol/day [1] and that the average water content of the body
is 80% by weight, this leads to an approximate CO concen-
tration of 8 AM in an 80 kg man. This latter calculation may
be an over-estimate considering the half-life and elimination
of CO. However, on the other hand, the local concentration
of CO could be much higher in some microenvironments
within the cell. Clearly, our calculation is only approximate,
and provides some idea of the CO concentrations that exist.
Considering this, the estimated concentration of CO used inour experiments (14.4 AM) was similar to physiological
levels (8 AM). As a measure of NO levels in culture media,
nitrite generated by GSNO was measured after a 180 min
incubation at 37 jC with this agent and was equal to 50 AM
[8]. For comparison, the concentration of nitrite in the serum
of normal human subjects is approximately 20 AM and this
can increase to 250 AM in pregnancy [32]. Thus, the levels of
NO used in the current study are similar to that found under
biologically relevant conditions.
The decrease in 59Fe uptake from 59Fe–Tf in the pres-
ence of CO or NO could relate to a decrease in Tf-binding to
the TfR1. To determine if this was the case, Tf was labelled
with both 59Fe and 125I and the internalisation of the
molecule examined in the presence of 2% CO gas and
GSNO (0.5 mM). Neither NO nor CO had any effect on the
internalisation of 125I-Tf (0.75 AM) over incubation periods
up to 180 min at 37 jC (data not shown). This result with
NO confirms our data from a previous investigation [10].
The decrease in 59Fe uptake from 59Fe–Tf by CO may be
explained by the ability of CO to bind to Fe within the
binding sites of Tf and perturb the ability of the protein to
release the metal ion. Indeed, strong ligands such as CN 
have been reported to be capable of binding to Fe within Tf
[33]. To examine this possibility, a solution of unlabelled
diferric Tf (140 AM) was incubated for 180 min at 37 jC
with 2% CO using the same conditions as that implemented
in cell culture experiments. The effect of CO on the UV–
Vis absorption peak of Tf at 465 nm [26] was monitored
before and after the incubation. However, no change in the
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inhibiting 59Fe uptake from 59Fe–Tf was not due to its
ability to directly perturb the Fe-binding sites of Tf.
Considering that previous studies demonstrated that cells
transfected with HO1 and CPR resulted in decreased Fe
uptake [13], this effect could theoretically be due to other
products of haem degradation, namely Fe(II), bilirubin or
biliverdin (for review, see Ref. [2]). To test this, LMTK
cells were incubated with 59Fe–Tf (0.75 AM) and these
agents (1–50 AM) over a 180 min incubation at 37 jC.
Biliverdin or bilirubin had no effect on 59Fe uptake, whereas
the addition of Fe(II) (as FeSO4) to media increased
59Fe
uptake from 59Fe–Tf to 151F 28% and 143F 13% of the
control at Fe concentrations of 5 and 50 AM, respectively.
The effect of low Mr Fe at stimulating
59Fe uptake from
59Fe–Tf has been shown in our previous studies [25] (for
review, see Ref. [3]). Collectively, these data indicate that of
the haem degradation products generated by HO1, only CO
was active in terms of reducing 59Fe uptake from 59Fe–Tf.
3.2. Both CO and NO prevent iron uptake into ferritin
As CO and NO decreased 59Fe uptake from 59Fe–Tf
(Fig. 1A), the incorporation of 59Fe into ferritin by LMTK
cells during uptake was also examined after 60–180 min
incubation with GSNO (0.5 mM) or 2% CO (Fig. 1B). For
these experiments, we assessed the intracellular incorpora-
tion of 59Fe into ferritin using native-PAGE 59Fe-autoradi-
ography [20,27–29]. A band that co-migrated with horse
spleen ferritin and could be super-shifted with an anti-
ferritin antibody was identified using this technique (Fig.
1B), as described previously [20,29]. A band of low Mr
59Fe
can also be clearly observed that co-migrates with 59Fe-
citrate and can be removed by strong Fe chelators (e.g.,
DFO) (Fig. 1B) [27,28]. This band could represent 59Fe
released from cellular components by weak Fe chelators in
the lysis or running buffers (e.g., Tris) [27,28]. However, its
exact nature remains unclear and will not be further dis-
cussed in this investigation.
In control LMTK  cells, the level of 59Fe incorporated
into ferritin increased as a function of time up to 180 min at
37 jC (Fig. 1B), as described previously for this and other
cell types [20,28,29]. As the incubation time increased,
GSNO markedly inhibited 59Fe incorporation into ferritin
(Fig. 1B). Incubation with CO also caused an inhibition in
59Fe incorporation into ferritin compared to control cells,
but this was not as pronounced as that found in the presence
of GSNO. Together, these results indicate that NO and CO
can inhibit 59Fe uptake from 59Fe–Tf into cells and prevent
incorporation of 59Fe into ferritin.
3.3. Stable expression of HO1 and CPR in cells decreases
iron uptake from transferrin
The results above using exogenous CO demonstrated
that it was capable of markedly reducing 59Fe uptake from59Fe–Tf. Considering this, it was important to assess if
endogenously generated CO resulted in a similar effect.
Previous studies by Ferris et al. [13] using a HO1/CPR-
transfected kidney cell line showed that 59Fe uptake was
reduced compared to cells transfected with CPR alone.
However, these latter studies utilized radioactive Fe added
to FCS-containing media to label bovine Tf [13]. The
binding of radioactive Fe to bovine Tf was never con-
firmed and it is likely that excess radioactive Fe remained
as a low Mr form in the media, and this may confound the
interpretation. In fact, in this latter article, Fe uptake was
not linear as a function of incubation time as found for
other cell types [24], indicating a possible problem with
the labelling protocol. Moreover, while bovine Tf can
interact with the human TfR1, it has a different affinity
for this receptor than human Tf [34]. Thus, it was difficult
to compare this poorly defined labelling medium with our
results using purified Tf directly labelled with 59Fe. To
enable direct comparison of the results, we repeated the
studies of Ferris et al. [13] using 59Fe–Tf and the same
HO1- and CPR-transfected cell lines. Similar to these latter
studies, we showed using cells stably transfected with both
HO1 and CPR, that 59Fe uptake from 59Fe–Tf over a 180
min label was significantly ( P < 0.001) reduced to
26F 5% of that found for cells transfected with CPR only
(Fig. 1C).
Collectively, our experiments indicate that exogenous or
endogenous CO act similarly to NO resulting in a decrease
in 59Fe uptake from 59Fe–Tf that prevents 59Fe incorpora-
tion into ferritin.
3.4. Comparison of the effects of NO and CO on iron
mobilisation from cells
A number of studies have shown that NO (as NO.)
increases 59Fe mobilisation from cells [6,8,9,20,35]. Con-
sidering this, experiments were designed to compare the
effects of CO and NO on 59Fe mobilisation from prelabelled
LMTK  cells. This cell type was initially used since the
effect of NO on Fe metabolism and mobilisation has been
well characterized in this model [6,8,9,19,20].
After a 180 min label with 59Fe–Tf (0.75 AM), the
cells were washed and reincubated with fresh media for
5–180 min at 37 jC in the presence or absence of GSNO
(0.5 mM), GSH (0.5 mM), or 2% CO (Fig. 2A). In the
presence of control medium, the percentage of total 59Fe
released from cells was between 5% and 10% during the
time course (Fig. 2A). When cells were incubated with
GSNO, the percentage of total cellular 59Fe release in-
creased from 6% after 5 min to 28% after a 180 min
incubation at 37 jC (Fig. 2A). In contrast, the GSNO
control, GSH, resulted in no significant 59Fe release as
compared to control cells (Fig. 2A), as demonstrated in
our previous investigations [6,8]. The ability of NO to
induce 59Fe release from prelabelled cells was also ob-
served for several other NO-generating agents, including
Fig. 2. (A) The NO donor GSNO but not CO gas results in 59Fe mobilisation from prelabelled LMTK fibroblasts. (B) Iron mobilisation from LMTK
fibroblasts prelabelled for various times in the presence of GSNO, CO gas, or a combination of both. (A) Cells were prelabelled with 59Fe–Tf (0.75 AM) for
180 min at 37 jC, washed, and then reincubated for up to 180 min at 37 jC with GSNO (0.5 mM), GSH (0.5 mM) or 2% CO gas. Results are means of
duplicate determinations in a typical experiment from three performed. (B) Cells were prelabelled with 59Fe–Tf (0.75 AM) for 15–180 min at 37 jC, and then
reincubated for 180 min with GSNO (0.5 mM), 2% CO gas, or GSNO and 2% CO gas. Results are expressed as meanF S.D. of triplicate determinations in a
typical experiment of three experiments performed.
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without the NO group (i.e., N-acetylpenicillamine and
spermine, respectively) [6, 8]. Interestingly, in contrast to
the observation that CO acted similarly to NO by inhibit-
ing 59Fe uptake from 59Fe–Tf by LMTK  cells (Fig.
1A), CO caused no significant 59Fe efflux from this cell
type as compared to the control (Fig. 2A). Experiments
with [Ru(CO)3Cl2]2 (25–150 AM) over a 180 min incu-
bation also resulted in no 59Fe mobilisation from prela-
belled cells.
When Fe(III) enters cells bound to Tf, it is subsequently
reduced to Fe(II) and transported through the endosomal
membrane [2,3]. The Fe(II) is then used for metabolism
and can be stored in ferritin as Fe(III) [2,3]. It has been
shown that as the labelling time with 59Fe–Tf increases,
NO and Fe chelators are less effective at removing 59Fe
from cells, as Fe becomes incorporated into less accessible
pools [8,28]. As CO binds Fe(II) and not Fe(III) [2], it is
possible that it may be more effective at binding Fe after
relatively short labelling periods. To test this, the effect of
labelling time with 59Fe–Tf was assessed on 59Fe efflux
from LMTK  cells. Cells were prelabelled with 59Fe–Tf
(0.75 AM) for incubation periods from 15 to 180 min at 37
jC, washed, and then reincubated for 180 min at 37 jC in
the presence of either control medium, GSNO (0.5 mM),
2% CO, or GSNO (0.5 mM) and 2% CO (Fig. 2B). When
cells were incubated in control medium only, the percent-
age of cellular 59Fe release decreased from 14F 5% after a
15 min label to 6F 2% after a 180 min label (Fig. 2B).
This demonstrated that as the labelling time with 59Fe–Tf
increased, 59Fe was being incorporated into more inacces-
sible compartments. When LMTK cells were reincubated
in the presence of GSNO, the percentage of total 59Fe
released from cells was 2–3-fold greater than control cells
at all labelling times (Fig. 2B). However, similarly tocontrol cells, as the prelabelling time with 59Fe–Tf in-
creased, NO-mediated 59Fe removal from cells decreased
significantly (P < 0.0001) from 47F 2% after a 15 min
label to 25F 1% after a 180 min label (Fig. 2B). Reincu-
bation of cells prelabelled with 59Fe–Tf for 15 min to 180
min in the presence of 2% CO, showed no significant
effect on 59Fe efflux compared to control cells incubated
with media alone. Moreover, combination of CO and
GSNO resulted in no synergistic or inhibitory effects
(Fig. 2B).
Experiments with oxyHb were performed to determine
its effect on NO and CO and their ability to induce 59Fe
release from prelabelled LMTK cells. Cells were la-
belled with 59Fe–Tf (0.75 AM) for 180 min at 37 jC,
washed, and then reincubated for 180 min at 37 jC in the
presence of GSNO (0.5 mM) or 2% CO gas in the
presence or absence of oxyHb (250 AM). Reincubation
of cells in the presence of control medium resulted in the
release of 3F 1% cellular 59Fe and this was increased to
22F 1% in the presence of GSNO. The presence of
oxyHb had no effect on 59Fe release from control cells
but completely inhibited GSNO-mediated 59Fe release
resulting in the efflux of 3F 1% of cellular 59Fe. These
results were consistent with oxyHb acting as a scavenger
for NO. Reincubation with CO did not significantly
increase cellular 59Fe release when compared to the
control, but surprisingly, the addition of oxyHb resulted
in 17F 1% of cellular 59Fe being released compared to
control medium that induced the efflux of 3F 1% (data
not shown). The ability of oxyHb to increase 59Fe release
from cells in the presence of CO was shown to be due to
marked cell death that did not occur in the presence of
either 2% CO or oxyHb alone. As described above, we
showed that oxyHb acted as a ‘‘CO-sink’’ to increase CO
concentrations in the media. In this way, the subsequent
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bioavailability of CO to the cells resulting in pronounced
cytotoxicity.
To assess if the results obtained with LMTK  fibro-
blasts were representative of a general response to CO, a
panel of eight cell types commonly used in our laboratory
were then assessed for the ability of NO or CO at inducing
cellular 59Fe mobilisation (Fig. 3A). In these experiments,Fig. 3. (A) GSNO results in 59Fe mobilisation from eight human and murine cell
from human MCF7 cells. (B) Cellular iron mobilisation is slightly increased from
stably transfected with CPR alone. (C) NO but not CO decreases ferritin 59Fe levels
AM), washed, and reincubated for 180 min at 37 jC with GSNO (0.5 mM) or 2%
typical experiment of two performed. (B) Cells were prelabelled as in panel (A), wa
are expressed as meanF S.D. of three experiments with triplicates in each experim
panel (A) and then subjected to native PAGE-59Fe autoradiography (see Materia
autoradiograph. The results are a typical experiment from six performed.cells were prelabelled with 59Fe–Tf (0.75 AM) for 180 min
at 37 jC, washed, and then reincubated for 180 min at 37
jC in the presence or absence of GSNO (0.5 mM) or 2%
CO gas (Fig. 3A). These studies showed that NO induced
59Fe mobilisation from all cell types tested, while CO was
not effective in inducing significant (P >0.05) 59Fe efflux
in seven cell lines. However, a marked and significant
(P < 0.001) increase in 59Fe release was observed fromtypes while CO gas is only effective at inducing marked 59Fe mobilisation
HEK-293 cells stably transfected with HO1 and CPR compared to those
in prelabelled LMTK cells. (A) Cells were prelabelled with 59Fe–Tf (0.75
CO gas. Results are expressed as meanF S.D. of three determinations in a
shed, and then reincubated in control medium for 180 min at 37 jC. Results
ent. (C) Cells were prelabelled and reincubated with GSNO or CO gas as in
ls and methods for details). Densitometric analysis is presented below the
Fig. 4. Glutathione-depletion using BSO reduces 59Fe mobilisation from
MCF-7 cells mediated by GSNO but not CO. The MCF7 cells were
incubated for 20 h at 37 jC in the presence and absence of BSO (0.01 mM).
After this incubation, the cells were washed twice, and then prelabelled
with 59Fe–Tf (0.75 AM) for 180 min at 37 jC, washed, and reincubated for
180 min at 37 jC in control medium or medium containing GSNO (0.5
mM) or 2% CO gas. The results are expressed as meanF S.D. of three
determinations in a typical experiment of two performed.
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incubation with CO, phase-contrast microscopy showed
that in contrast to the other cell types, some cell death
was evident in MCF7 cultures, an observation supported
by Trypan blue staining. These experiments suggested the
59Fe release found from MCF7 cells may be due to the
cytotoxic effects of CO. However, to ensure that 59Fe
release was not occurring by a process requiring cellular
metabolism, further experiments were performed to deter-
mine if CO-mediated 59Fe release was dependent on GSH
(see below).
To determine whether endogenously generated CO could
induce 59Fe mobilisation, cells stably expressing HO1 and
CPR were compared to those expressing CPR only (Fig.
3B). In these experiments, cells were labelled with 59Fe–Tf
(0.75 AM) for 180 min at 37 jC, washed, and then
reincubated for 180 min at 37 jC in medium. The 59Fe
mobilisation from labelled HO1 and CPR transfected cells
was about 2-fold that found for CPR cells, and was found to
be significantly different over three experiments (P < 0.01)
(Fig. 3B). These results are similar to those obtained
previously by Ferris et al. [13], where Fe release was also
increased by 2-fold.
3.5. NO, but not CO, decreases 59Fe-ferritin levels in 59Fe-
prelabelled cells
While extracellular generation of CO had little effect on
59Fe mobilisation from cells, further studies examined if
CO and NO could alter the intracellular distribution of
59Fe in cells prelabelled with 59Fe–Tf (Fig. 3C). This was
performed using native PAGE 59Fe-autoradiography
[20,27–29]. In these experiments, LMTK  fibroblasts
were labelled with 59Fe–Tf (0.75 AM) for 180 min at 37
jC, washed, and then reincubated for 180 min at 37 jC
with control medium or medium containing GSNO (0.5
mM) or 2% CO. The cells were then lysed and subjected
to native PAGE-59Fe autoradiography (Fig. 3C).
The autoradiograph shows that when cells were reincu-
bated with GSNO, the ferritin-59Fe levels decreased during
the 180 min period to 30% of the control (Fig. 3C), an
observation consistent with our previous study [20]. How-
ever, reincubation in the presence of 2% CO did not alter
the level of ferritin-59Fe (Fig. 3C). Shorter incubations of
1–2 h also showed that CO had no effect (data not
shown). These results indicate that in contrast to NO,
CO does not affect ferritin-59Fe levels in cell prelabelled
with 59Fe–Tf.
3.6. Unlike NO-mediated iron efflux, CO-mediated iron
mobilisation is not dependent on cellular GSH levels
NO-mediated Fe efflux has been shown to be both
energy- and GSH-dependent [8,20]. Considering that
dithiol-dinitrosyl-Fe complexes have been identified in
NO-treated cells [36], we hypothesised that dinitroso-diglutathionyl-Fe complexes were released from cells
[8,20]. Previous studies have indicated that carbonyl-
thiol-Fe complexes can also form [37,38], thus we exam-
ined whether the CO-mediated 59Fe efflux observed from
MCF7 cells (see Fig. 3A) was GSH-dependent. In these
experiments, cells were depleted of GSH by pre-treatment
for 20 h with the g-glutamylcysteine synthetase inhibitor,
BSO (0.01 mM) [8], while control cells were preincu-
bated with MEM only. We have previously demonstrated
that these incubation conditions with BSO markedly
reduce GSH levels without affecting cellular viability
[8]. The MEM or BSO-treated MCF7 cells were then
labelled with 59Fe–Tf (0.75 AM) for 180 min at 37 jC,
washed, and reincubated for 180 min at 37 jC in control
medium or this medium containing GSNO (0.5 mM) or
2% CO.
There was no significant difference in 59Fe efflux
between MEM and BSO-preincubated control cells
(100F 19% compared to 112F 14%, respectively), indi-
cating that GSH-depletion had no effect on basal 59Fe
release (Fig. 4). Experiments to assess GSH depletion
demonstrated that in BSO-treated samples, GSH levels
had decreased to 30% of the control value [8]. Also, in
accordance with our previous studies [8], preincubation
with BSO significantly (P < 0.0001) decreased NO-medi-
ated 59Fe mobilisation when comparing cells preincubated
with MEM (309F 7% of the control) to those incubated
with BSO (145F 13% of the control; Fig. 4). However,
preincubation with BSO did not depress CO-mediated
59Fe efflux from MCF-7 cells, which actually increased
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452F 28% of the control in those incubated with BSO
(Fig. 4). Similar experiments were also performed com-
paring the effect of BSO on the slight increase in 59Fe
release (Fig. 3B) observed from HO1/CPR cells compared
to those transfected with CPR only. After incubation with
BSO, 59Fe efflux from the HO1/CPR cells remained 2-
fold higher than the 59Fe efflux from CPR cells, indicat-
ing that GSH was not necessary for HO1-mediated 59Fe
efflux to occur (data not shown). Incubation of these
stably transfected cell types in the presence of GSNO
resulted in an increase in 59Fe efflux from both cell types
to 22F 1% in CPR and 24F 1% in HO1/CPR, respec-
tively. However, when cells were pre-treated with BSO,
the NO-mediated 59Fe efflux decreased to 3F 1% in
CPR- and 6F 1% HO1/CPR-transfected cells, respective-
ly. This BSO-mediated decrease in NO-mediated 59Fe
efflux agrees with our previous work [8,20]. Collectively,
the results indicate that NO-mediated 59Fe release was
GSH-dependent, while that found for CO was independent
of this molecule.
3.7. The effect of combining NO and CO on cellular iron
metabolism
As CO and NO can be synthesized at similar sites, it
has been postulated that they could work synergistically
or antagonistically towards each other [39] (for reviews,
see Refs. [1,2]). Furthermore, CO could displace NO
from haemoproteins, thereby mobilising intracellular NO
pools, as seen under other conditions [40,41]. To observe
if there were any synergistic or antagonistic interactions
between CO and NO on cellular 59Fe uptake, LMTK
cells were incubated with 59Fe–Tf (0.75 AM) for 180Fig. 5. The combination of CO and GSNO acts synergistically to reduce 59Fe u
increase 59Fe mobilisation from prelabelled LMTK cells (B). (A) Cells were in
absence of GSNO (0.5 mM), 2% CO, or GSNO (0.5 mM) and 2% CO. The cells w
cells with Pronase (1 mg/ml) for 30 min at 4 jC. (B) Cells were labelled for 180 m
min at 37 jC in the presence or absence of GSNO (0.5 mM), 2% CO, or GSNO
determinations from a typical experiment of three performed.min in the presence of 2% CO, GSNO (0.5 mM) or both
(Fig. 5A).
The effects of co-incubation with 2% CO and GSNO on
59Fe uptake from 59Fe–Tf are shown in Fig. 5A. Individ-
ually, GSNO and 2% CO inhibited 59Fe uptake from 59Fe–
Tf to 62F 5% and 37F 1% of control samples, respectively
(Fig. 5A). When cells were incubated with 59Fe–Tf in the
presence of both CO and GSNO, there was a significant
(P < 0.001) synergistic effect, which inhibited 59Fe uptake
to 24F 1% of the control (Fig. 5A).
To examine the effects of combining CO and NO on
59Fe mobilisation from cells, LMTK  fibroblasts were
labelled with 59Fe–Tf (0.75 AM) for 180 min at 37 jC,
washed, and then reincubated with either control medium,
GSNO (0.5 mM), 2% CO, or GSNO (0.5 mM) and 2%
CO (Fig. 5B). Incubation with GSNO resulted in the
release of 22F 1% of total cellular 59Fe, while control
medium resulted in the release of 3F 1% of total 59Fe. In
contrast, incubation with CO had no significant effect on
59Fe mobilisation compared to the control (Fig. 5B). Co-
incubation of CO and NO did not enhance nor decrease
NO-mediated 59Fe efflux (Fig. 5B).
It is well known that the uptake of 59Fe–Tf is ATP-
dependent [11] and that NO inhibits 59Fe uptake from
59Fe–Tf, at least in part, by decreasing ATP levels [9].
Hence, we examined the ATP levels of LMTK  cells
incubated with CO, GSNO, or both under the same
incubation conditions as found in Fig. 5A. After a 180
min incubation, GSNO reduced ATP levels to 43F 1% of
the control, while CO reduced ATP levels to only 74F 5%
of control (Fig. 6A). When GSNO and CO were co-
incubated with LMTK cells for 180 min at 37 jC, ATP
levels decreased to 38F 1% of the control, which was only
slightly less than that found with NO alone (Fig. 6A).ptake from 59Fe-transferrin by LMTK cells (A), but do not synergise to
cubated for 180 min at 37 jC with 59Fe–Tf (0.75 AM) in the presence or
ere then washed and internalised 59Fe uptake determined by incubating the
in at 37 jC with 59Fe–Tf (0.75 AM), washed, and then reincubated for 180
(0.5 mM) and 2% CO. The results are expressed as meanF S.D. of three
Fig. 6. Both GSNO and CO gas decrease cellular ATP levels (A) and D-glucose can partially rescue the effect of NO but not CO at decreasing 59Fe uptake from
59Fe-transferrin by LMTK cells. (A) LMTK cells were incubated for 180 min at 37 jC with GSNO (0.5 mM), 2% CO or 2% CO and GSNO (0.5 mM). Cells
were then lysed and ATP levels assayed (see Materials and methods). (B) LMTK cells were incubated with 59Fe–Tf (0.75 AM) for 180 min at 37 jC in the
presence or absence of D-glucose (11 mM) or D-fructose (11 mM), or alternatively, 59Fe–Tf (0.75 AM) and GSNO (0.5 mM) or 2% CO in the presence or
absence of either monosaccharide (11 mM). Results are expressed as meanF S.D. of three determinations in a typical experiment of three performed.
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or CO can decrease 59Fe uptake from 59Fe–Tf, with some
synergistic effect being observed on 59Fe uptake.
To further investigate the ability of NO and CO to reduce
ATP levels and 59Fe uptake by LMTK fibroblasts, we
examined the ability of D-glucose to act as a salvage
metabolite to rescue 59Fe uptake from 59Fe–Tf (Fig. 6B).
As a control for the metabolisable substrate, D-glucose, we
used D-fructose which cannot be metabolised by fibroblasts
[42] and does not increase ATP levels or stimulate NO-
mediated 59Fe release [8,9]. In these studies, cells were
incubated for 180 min at 37 jC in media containing 59Fe–
Tf (0.75 AM) with or without 2% CO gas or GSNO (0.5
mM) in the presence or absence of D-glucose (11 mM) or
D-fructose (11 mM) (Fig. 6B). The presence of D-glucose
had no significant effect on the ability of CO to inhibit 59Fe
uptake from 59Fe–Tf. However, D-glucose significantly
(P < 0.01) rescued NO-mediated inhibition of 59Fe uptake
from 59Fe–Tf, increasing it from 24F 2% to 48F 4% of the
control in the absence or presence of D-glucose, respectively
(Fig. 6B). In contrast, D-fructose had no significant effect on
59Fe uptake in the presence or absence of CO or NO (Fig.
6B). Hence, in contrast to NO, D-glucose did not act as a
salvage metabolite to prevent the CO-mediated decrease in
59Fe uptake from 59Fe–Tf.
3.8. In contrast to NO, CO does not increase IRP1-RNA-
binding activity in LMTK fibroblasts
It is well known that NO can increase IRP1-mRNA
binding [4,14,15,19] by two possible mechanisms, namely
by directly attacking the [4Fe–4S] cluster and by depleting
the intracellular Fe pool and causing Fe mobilisation [4,6–
8,20]. To examine the effects of CO on IRP1-mRNA
binding activity, the CO-donor [Ru(CO)3Cl2]2 [18] wasused at concentrations from 50 to 150 AM (Fig. 7). Since
Fe-deprivation increases IRP-RNA-binding activity mark-
edly only after an incubation of 180 min [43], we used
[Ru(CO)3Cl2]2 in preference to CO gas which caused
cytotoxicity after this time. The Fe chelator, DFO (100
AM), was used as a positive control since this concentration
is known to deplete intracellular Fe pools and increase IRP-
RNA-binding activity [4,6,19,43].
As expected, LMTK  cells incubated for 24 h with
100 AM DFO showed a 2-fold increase in active IRP1-
RNA binding activity compared to the control sample,
while there was no change in total IRP1-RNA-binding as
judged from the addition of h-mercaptoethanol [4,6,19,43]
(Fig. 7A). It should be noted that the LMTK  cell type
does not contain appreciable quantities of IRP2, as de-
scribed previously [6]. When cells were incubated with
[Ru(CO)3Cl2]2 at 50, 100 and 150 AM, there was no
marked change in active IRP1-RNA-binding activity when
compared to the control (Fig. 7A). However, the control
compound, RuCl3, appeared to slightly increase IRP1-
RNA binding at all concentrations used. These results
showed that [Ru(CO)3Cl2]2 does not activate IRP1-mRNA
binding activity. Experiments incubating LMTK cells
with 2% CO gas also showed that after a 180 min
incubation at 37 jC, IRP1-RNA-binding was not increased
(data not shown). As a positive control, LMTK cells were
incubated with the NO-generating agents, SNAP (0.5 mM)
or GSNO (0.5 mM) (Fig. 7B). These agents resulted in an
increase in active IRP1-RNA-binding activity but had no
effect on total binding (Fig. 7B), as shown previously [6,7]
(for reviews, see Refs. [3,4]). The precursor compounds of
these NO generators, namely NAP and GSH, respectively,
that do not have the NO-group had no effect on active nor
total IRP1-RNA-binding activity (Fig. 7B). Incubation of
cells with other NO generators, such as SperNO, resulted
Fig. 7. The CO-generating agent, ([Ru(CO)3Cl2]2), does not activate iron-
regulatory protein-1 (IRP1) RNA-binding activity in LMTK fibroblasts
(A), in contrast to the NO generators, GSNO or SNAP (B). (A) Cells were
incubated for 24 h at 37 jC with either DFO (100 AM), [Ru(CO)3Cl2]2
(50–150 AM) or RuCl3 (50–150 AM). The cells were then lysed and IRP1-
RNA binding activity assessed as described in Materials and methods. (B)
Cells were incubated for 24 h at 37 jC with either SNAP (0.5 mM) or
GSNO (0.5 mM) or their precursor compounds, NAP (0.5 mM) or GSH
(0.5 mM), respectively, that do not have the NO group. The cells were then
processed as described in panel (A). Densitometric analysis of the data is
presented below each autoradiograph. The results are typical experiments
from five performed.
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[6,7]. Our results clearly demonstrate the effect of NO on
IRP-RNA-binding activity was very different to that of CO
which had no effect.4. Discussion
While much is known about the influence of NO on Fe
metabolism [2–4,6–10,14], investigation of the effects of
CO on intracellular Fe is still in its infancy [2]. It has been
hypothesised that the interaction of NO with Fe could
mediate, at least in part, the cytotoxic effector mechanism
of activated macrophages against tumour cells and patho-
gens [35]. Since CO shares similarities to NO in some of its
coordination chemistry and ability to bind Fe(II) in haemo-
proteins, it has been suggested that they could have a similar
effect and act synergistically on cellular Fe metabolism and
many physiological and pathophysiological processes [1,2].
Alternatively, CO and NO may counteract each other by
competing for binding to Fe(II) in haemoproteins and other
molecules [2]. Thus, the effects of CO and NO on Fe
trafficking are important to assess.
For the first time, this investigation compared the effect
of NO and CO on cellular Fe metabolism. We have shown
that authentic CO gas or the synthetic CO donor,
[Ru(CO)3Cl2]2, decreased cellular
59Fe uptake from 59Fe–
Tf (Figs. 1A, 5A, 6B). Significantly, the inhibition of 59Fe
uptake was not observed with the other products of HO1-
mediated haem degradation, namely Fe(II), biliverdin or
bilirubin. These results suggest that the inhibition of 59Fe
uptake from 59Fe–Tf observed in HO1/CPR-transfected
cells (Fig. 1C and Ref. [13]) was due to CO released during
haem degradation.
We have shown in past studies that the inhibition of 59Fe
uptake from 59Fe–Tf by NO correlated with ATP depletion
[9]. In our current work, we demonstrated that ATP was
decreased in cells incubated with NO and CO, but despite
the fact that CO reduced 59Fe uptake more effectively than
NO (Fig. 5A), CO had less effect on ATP levels than NO
(Fig. 6A). Furthermore, while D-glucose could partially
rescue NO-mediated 59Fe uptake from 59Fe–Tf, it could
not rescue the ability of CO to inhibit 59Fe uptake (Fig. 6B).
These experiments suggest that the generation of CO may
prevent 59Fe uptake from 59Fe–Tf through another mecha-
nism in addition to its ability to reduce ATP levels. Con-
sidering this, it is unlikely that CO would bind to the high
spin Fe(III) atom within the Tf-binding site, as this ligand
prefers Fe(II) [2]. Indeed, UV–Vis absorbance spectropho-
tometry experiments in the current study did not detect any
change in the charge-transfer band of Tf at 465 nm,
indicating no marked alterations to the Fe-binding site.
However, as CO binds to Fe(II), and since Fe is found in
this state after its release from Tf in the endosome [3], it can
be hypothesised that CO chelates Fe(II) before or soon after
it leaves the vesicle, inhibiting it from entering the cell.
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prevents Fe uptake from Tf, these data indicate that like
NO, CO could inhibit proliferation. In fact, it has been
demonstrated that CO generated by HO1 can act as an
autocrine inhibitor of smooth muscle growth [44]. Further,
since growth factors can alter the expression of HO1
[45,46], it seems likely that CO could modulate or fine-
tune proliferation. As NO can induce HO1 expression [47],
it may be expected that the NO generated by inducible
nitric oxide synthase (iNOS) in activated macrophages
could increase HO1 levels and CO generation. Hence,
both CO and NO could be produced by macrophages to
act as cytotoxic effector molecules against tumour cells
and parasites. Part of the action of CO and NO may be
mediated by their ability to prevent Fe uptake from Tf and
to target haem-containing proteins. Further studies exam-
ining the co-expression of HO1 and iNOS in activated
macrophages from tumours or parasitic infections are
essential to assess this hypothesis.
The degradation of haem by HO1 results in the stoi-
chiometric release of Fe(II), CO and other products [1,2].
Since CO has a high affinity for Fe(II) and because
carbonyl-thiol-Fe complexes have been shown to form in
vitro [37,38], it could be speculated that CO forms
lipophilic intracellular complexes which are subsequently
released from the cell. This mechanism of Fe release could
be reminiscent of that postulated for NO [2], which forms
intracellular Fe-NO-thiol complexes [36], and is released
in a GSH-dependent manner [8,20], possibly as a GS-Fe-
NO complex [2,8,20]. Hence, we investigated the ability of
exogenous or endogenous CO to act as an Fe chelator to
mobilise Fe from cells and the dependence of this process
on GSH. In a panel of eight cell types, NO produced by
GSNO acted to increase 59Fe release from all, in agree-
ment with our previous studies [6,8,20]. In contrast, CO
only resulted in significant 59Fe release from MCF7 cells,
an effect independent of GSH depletion (Fig. 4) and
probably due to the sensitivity of these cells to the
cytotoxic activity of CO. These results indicated that
unlike NO, CO was not effective at entering cells, binding
Fe, and causing Fe mobilisation. Furthermore, despite the
increase in 59Fe release from HO1/CPR-transfected cells in
this study (Fig. 3B) and previous investigations [13], the
extent of this effect was not as marked as that seen on Fe
uptake (Fig. 1C).
It is of interest to discuss the tentatively contrasting
result of the effect of CO on ferritin-59Fe levels during Fe
uptake compared to when cells were prelabelled with
59Fe–Tf (cf. Figs. 1B and 3C). In the present study, we
showed that CO decreases Fe uptake into cells (Fig. 1A),
and thus reduces the amount of Fe available to be
incorporated into ferritin. Transferrin-bound Fe(III) is
converted to Fe(II) in the endosome before transport into
the cytosol via Nramp2 [3]. Once in the cytosol, the
majority of Fe is incorporated into ferritin [3,28,29].
During Fe uptake, CO may bind to Fe(II) before or verysoon after it has left the vesicle and prior to its incorpo-
ration into ferritin, thus blocking its accumulation in the
core of this protein. Conversely, during Fe mobilisation
studies, the 59Fe has already entered the cells or ferritin,
and hence, a significant proportion would in the Fe(III)
state. Since CO preferably binds Fe(II) [1,2], this would
decrease the ability of CO to bind Fe, and consequently
have no effect on ferritin-Fe levels. As CO did not cause
59Fe mobilisation from prelabelled LMTK cells (Figs.
2A and 3A), the 59Fe was also not removed from ferritin
(Fig. 3C).
In view of the general lack of CO-mediated Fe efflux
from cells compared to NO-mediated Fe mobilisation (Figs.
2A and 3A), it can be hypothesised that CO can bind to Fe
but not remove it from proteins. In fact, it has been shown
that CO can bind to Fe within several [Fe–S] clusters
including the Mo–Fe nitrogenase protein [48] and the Fe-
only hydrogenase (Cp1) from Clostridium pasteurianum
[49]. However, CO has not been reported to disrupt [Fe–
S] clusters. In contrast, NO binds to the [Fe–S] cluster of
various proteins, and in IRP1, causes the removal of at least
one Fe atom, disrupting the cluster and increasing IRP1-
RNA-binding activity [4,6,7,14,30,50].
The results described above suggest differences in the
interaction of NO and CO with cellular Fe pools, despite
their similar coordination chemistry. Considering this,
within haem, CO preferentially binds Fe in a linear
geometry, perpendicular to the plane of the haem centre
[50]. However, due to steric influences within a protein,
CO is often forced to bind at an angle, thus causing a
relatively weak bond between CO and Fe [50]. On the
other hand, while the NO molecule is closely akin to CO,
it contains one more electron, and can bind in a ‘‘bent’’
geometry with Fe in haem with much stronger affinity
than CO (for review, see Ref. [50]). NO can also displace
the trans ligand from haem proteins, thus forming a five-
coordinate Fe complex that can cause a conformational
change critical for mediating functional alterations [50].
Conversely, CO does not have this ability, indicating
additional differences in the effects of CO and NO on
Fe centres in proteins [50]. Other differences in their
chemistry, e.g., lipophilicity, stability, and ability to un-
dergo redox reactions (e.g., as for NO), could lead to
changes in their ability to enter certain intracellular Fe-
containing compartments to bind Fe and effect efflux.
This lack of effect with CO on [Fe–S] clusters and its
inability to induce Fe release probably explains its inef-
fectiveness at increasing IRP1-RNA-binding activity in
this study.
In summary, the results presented in this paper demon-
strate that both NO and CO reduce Fe uptake from Tf and its
subsequent incorporation into ferritin. The mechanism of
this effect may involve the ability of CO to intercept Fe(II)
very soon after its release from the high affinity Tf–Fe-
binding sites in the cell. However, in marked contrast to NO,
CO was not effective at mobilising Fe from cells or
R.N. Watts, D.R. Richardson / Biochimica et Biophysica Acta 1692 (2004) 1–1514increasing IRP1-RNA-binding activity, suggesting funda-
mental differences in the effects of these ligands on cellular
Fe pools. Hence, despite many similarities in the chemical
and biological effects of CO and NO, the subtle differences
cause a major divergence in their effects on cellular Fe
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